compound 3 [PMID: 32258933]   Click here for help

GtoPdb Ligand ID: 11214

Antimalarial Ligand
Compound class: Synthetic organic
Comment: Compound 3 is the lead for a novel series of antimalarial compounds based on a benzimidazole core [1].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 33.09
Molecular weight 326.13
XLogP 4.18
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Clc1ccc2c(c1)nc(n2Cc1ccccc1)N1CCNCC1
Isomeric SMILES Clc1ccc2c(c1)nc(n2Cc1ccccc1)N1CCNCC1
InChI InChI=1S/C18H19ClN4/c19-15-6-7-17-16(12-15)21-18(22-10-8-20-9-11-22)23(17)13-14-4-2-1-3-5-14/h1-7,12,20H,8-11,13H2
Guide to Malaria Pharmacology Comments
A phenotypic high-throughput screen of the Novartis chemical library, followed by a hit to lead effort, identified compound 3 as an early lead with promising antimalarial activity [1]. SAR analysis was carried out but further optimization will be necessary to improve pharmacokinetic properties and address potential cardiotoxicity issues.

Potential Target/Mechanism Of Action: As the precise mechanism of action of compound 3 is not yet known, we do not have a molecular target for this compound.